Dr. Vicini on Accelerated Partial Breast Irradiation in Low-Risk Breast Cancer

Frank A. Vicini, MD
Published: Thursday, Oct 29, 2015



Frank A. Vicini, MD, radiation oncologist, 21st Century Oncology of Michigan, discusses a European study that examined the efficacy of accelerated partial breast irradiation (APBI) versus conventional whole breast irradiation (WBI) in patients with low-risk breast cancer.

The multicenter European noninferiority phase III study demonstrated noninferiority of APBI compared with WBI for select patients with early-stage breast cancer. It is also the first large trial that addresses this topic, Vicini adds. Patients were closely followed, and techniques were done consistently.

Data from this study show that the paradigm for treating these select patients should change in centers beyond Europe, Vicini explains.



Frank A. Vicini, MD, radiation oncologist, 21st Century Oncology of Michigan, discusses a European study that examined the efficacy of accelerated partial breast irradiation (APBI) versus conventional whole breast irradiation (WBI) in patients with low-risk breast cancer.

The multicenter European noninferiority phase III study demonstrated noninferiority of APBI compared with WBI for select patients with early-stage breast cancer. It is also the first large trial that addresses this topic, Vicini adds. Patients were closely followed, and techniques were done consistently.

Data from this study show that the paradigm for treating these select patients should change in centers beyond Europe, Vicini explains.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: Medical Crossfire®: Translating Lessons Learned with PARP Inhibition to the Treatment of Breast Cancer—Expert Exchanges on Novel Strategies to Personalize CareAug 29, 20181.5
Publication Bottom Border
Border Publication
x